A clinical case of exocrine pancreatic insufficiency in a patient with type 1 diabetes mellitus
https://doi.org/10.14341/DM12884
Abstract
The pancreas belongs to the glands of mixed secretion and simultaneously performs both endo- and exocrine functions. Exocrine pancreatic insufficiency (EPI) is the general name for the malabsorption process caused by inadequate production and decreased activation of the enzymes of the pancreas acinar cells, such as amylase, lipase and protease, which are necessary for digestion. The prevalence of EPI in patients with type 1 diabetes, according to many authors, varies from 25 to 59%, which is determine by the data of pancreatic elastase-1. In this work, we present a clinical case of confirmed exocrine pancreatic insufficiency in a patient with a 6-year history of type 1 diabetes, which became the main cause of the development of episodes of hypoglycemia after meals. In the course of further studies, antibodies to lactoferrin and a reduced prostate volume, determined by MRI data, high levels of antibodies to glutamate decarboxylase and zinc co-transporter 8, as well as residual insulin secretion based on the level of C-peptide on an empty stomach detected.
About the Authors
M. R. RagimovRussian Federation
Magomedkerim R. Ragimov - MD, PhD student
11 Dm. Ulyanova street, 117036 Moscow
Competing Interests:
none
T. V. Nikonova
Russian Federation
Tatiana V. Nikonova - MD, PhD; Scopus Author ID: 55553886600.
Moscow
Competing Interests:
none
E. V. Marchenko
Russian Federation
Elena V. Marchenko - MD.
Moscow
Competing Interests:
none
N. M. Malysheva
Russian Federation
Natalia M. Malysheva - PhD in Biology; Scopus Author ID: 57197834989.
Moscow
Competing Interests:
none
O. S. Derevyanko
Russian Federation
Olga S. Derevyanko - MD, PhD; Scopus Author ID: 56095072000.
Moscow
Competing Interests:
none
References
1. DiMagno EP, Malagelada JR, Go VL, et al. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977;296(23):1318-1322. doi: https://doi.org/10.1056/NEJM197706092962304
2. Radlinger B, Ramoser G, Kaser S. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes. Curr Diab Rep. 2020;20(6):18. doi: https://doi.org/10.1007/s11892-020-01304-0
3. Hayden MR, Patel K, Habibi J, et al. Attenuation of Endocrine-Exocrine Pancreatic Communication in Type 2 Diabetes: Pancreatic Extracellular Matrix Ultrastructural Abnormalities. J Cardiometab Syndr. 2008;3(4):234-243. doi: https://doi.org/10.1111/j.1559-4572.2008.00024.x
4. Piciucchi M, Capurso G, Archibugi L, et al. Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol. 2015;2015:1-7. doi: https://doi.org/10.1155/2015/595649
5. Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;(68):18-22. doi: https://doi.org/10.1016/j.ejim.2019.07.021
6. Tod J, Fine D. Fecal elastase: a useful test for pancreatic insufficiency? Dig Dis Sci. 2010;55(10):2709-2711. doi: https://doi.org/10.1007/s10620-010-1409-9
7. Forsmark CE. Diagnosis and Management of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2018;16(3):306-315. doi: https://doi.org/10.1007/s11938-018-0186-y
8. Virostko J, Williams J, Hilmes M, et al. Pancreas volume declines during the first year after diagnosis of type 1 diabetes and exhibits altered diffusion at disease onset. Diabetes Care. 2019;42(2):248-257. doi: https://doi.org/10.2337/dc18-1507
9. Virostko J, Hilmes M, Eitel K, et al. Use of the electronic medical record to assess pancreas size in type 1 diabetes. PLoS One. 2016;11(7):e0158825. doi: https://doi.org/10.1371/journal.pone.0158825
10. Ragimov MR, Nikonova TV, Babaeva DM, et al. Structurall features of the pancreas in patients with type 1 diabetes mellitus. Diabetes Mellitus. 2022;25(3):239-248. (In Russ.) doi: https://doi.org/10.14341/DM12892
11. DeSouza SV, Singh RG, Yoon HD, et al. Pancreas volume in health and disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(8):757-766. doi: https://doi.org/10.1080/17474124.2018.1496015
12. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut. 1981;22(2):158-167. doi: https://doi.org/10.1136/gut.22.2.158
13. Hardt PD, Ewald N, Bröckling K, et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and non-alcoholic chronic pancreatitis. JOP. 2008;9(6):683-689.
14. Cesare E, Previti M, Lombardo F, et al. Prevalence of autoantibodies to carbonic anhydrase II and lactoferrin in patients with type 1 diabetes. Ann N Y Acad Sci. 2004;1037(1):131-132. doi: https://doi.org/10.1196/annals.1337.021
15. Pirart J. Diabetes Mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1(4):252-263. doi: https://doi.org/10.2337/diacare.1.4.252
16. Hardt PD, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res. 2011;2011:1-7. doi: https://doi.org/10.1155/2011/761950
17. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933-942. doi: https://doi.org/10.1002/ca.20543
18. Djuric-Stefanovic A, Masulovic D, Kostic J, et al. CT volumetry of normal pancreas: correlation with the pancreatic diameters measurable by the cross-sectional imaging, and relationship with the gender, age, and body constitution. Surg Radiol Anat. 2012;34(9):811-817. doi: https://doi.org/10.1007/s00276-012-0962-7
19. Wathle GK, Tjora E, Ersland L, et al. Assessment of exocrine pancreatic function by secretin-stimulated magnetic resonance cholangiopancreaticography and diffusion-weighted imaging in healthy controls. J Magn Reson Imaging. 2014;39(2):448-454. doi: https://doi.org/10.1002/jmri.24167
20. Kunovský L, Dítě P, Jabandžiev P, et al. Causes of exocrine pancreatic insufficiency other than chronic pancreatitis. J Clin Med. 2021;10(24):5779. doi: https://doi.org/10.3390/jcm10245779
Supplementary files
Review
For citations:
Ragimov M.R., Nikonova T.V., Marchenko E.V., Malysheva N.M., Derevyanko O.S. A clinical case of exocrine pancreatic insufficiency in a patient with type 1 diabetes mellitus. Diabetes mellitus. 2023;26(1):93-97. (In Russ.) https://doi.org/10.14341/DM12884

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).